ACCORD Trademark

Trademark Overview


On Tuesday, August 30, 2022, a trademark application was filed for ACCORD with the United States Patent and Trademark Office. The USPTO has given the ACCORD trademark a serial number of 97570474. The federal status of this trademark filing is REGISTERED as of Tuesday, July 23, 2024. This trademark is owned by Accord Healthcare, Inc.. The ACCORD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, non-prescription drugs and prescription medicine in the form of capsules, tablets, injectables, and creams for the treatment of various medical conditions, in particular, gout, depression, cancers, schizophrenia, opioid dependence withdrawal, anxiety, Parkinson's Disease, seizures, panic disorders, hypercalcemia, hypertension, multiple sclerosis, arrhythmia, hypercholesterolemia, diabetes, malaria, thyroid diseases, ADHD, asthma, allergies, transplant rejection prophylaxis, alcohol dependence, overactive bladder, pulmonary fibrosis, bipolar disorder, Restless leg syndrome, obsessive-compulsive disorder, premenstrual dysphoric disorder, post-traumatic stress disorder, hypertension, erectile dysfunction, atopic dermatitis, thrombosis, leukemia, Non-Hodgkin Lymphoma, skin infections, bloodstream infections, and hypotension
accord

General Information


Serial Number97570474
Word MarkACCORD
Filing DateTuesday, August 30, 2022
Status700 - REGISTERED
Status DateTuesday, July 23, 2024
Registration Number7452814
Registration DateTuesday, July 23, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Description of MarkThe mark consists of the word "ACCORD" in a stylized font, where the "a", "r" and "d" appear darker in shade than the "c" "c" and "o".
Goods and ServicesPharmaceutical preparations, namely, non-prescription drugs and prescription medicine in the form of capsules, tablets, injectables, and creams for the treatment of various medical conditions, in particular, gout, depression, cancers, schizophrenia, opioid dependence withdrawal, anxiety, Parkinson's Disease, seizures, panic disorders, hypercalcemia, hypertension, multiple sclerosis, arrhythmia, hypercholesterolemia, diabetes, malaria, thyroid diseases, ADHD, asthma, allergies, transplant rejection prophylaxis, alcohol dependence, overactive bladder, pulmonary fibrosis, bipolar disorder, Restless leg syndrome, obsessive-compulsive disorder, premenstrual dysphoric disorder, post-traumatic stress disorder, hypertension, erectile dysfunction, atopic dermatitis, thrombosis, leukemia, Non-Hodgkin Lymphoma, skin infections, bloodstream infections, and hypotension

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 16, 2022
Primary Code005
First Use Anywhere DateThursday, May 19, 2005
First Use In Commerce DateSunday, January 1, 2006

Trademark Owner History


Party NameAccord Healthcare, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameAccord Healthcare, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameAccord Healthcare, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Friday, September 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 2, 2022NEW APPLICATION ENTERED
Thursday, March 30, 2023ASSIGNED TO EXAMINER
Friday, March 31, 2023NON-FINAL ACTION WRITTEN
Friday, March 31, 2023NON-FINAL ACTION E-MAILED
Friday, March 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 23, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, June 23, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, September 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED